UNSPSC 51142509: Ropinirole

This classification denotes an antiparkinsonian agent with the molecular formula C16H24N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 030PYR8953, chemically known as 4-(2-dipropylaminoethyl)-1,3-dihydroindol-2-one but generally known as ropinirole, which bears US NIH Compound Identifier 5095. European Medicines Agency schedules Ropinirole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10380MIG.

UNSPSC 51142509 Ropinirole is a Commodity code that state and local governments nominally procure as a specific pharmaceutical product, but recent opportunities tagged under this code show little direct purchasing activity for ropinirole itself. Instead, the code appears in state and local solicitations addressing broader pharmaceutical procurement, opioid-response initiatives, and generic drug supply agreements where ropinirole may be one of many covered products rather than a primary line item. State and local issuing bodies pursuing pharmaceutical contracts include county health departments, state health and human services commissions, and multistate cooperative purchasing alliances. Seminole County, Florida, for example, recently issued an IFB for naloxone and drug deactivation systems as part of community health initiatives, while the Texas Health and Human Services Commission posted a Request for Information on direct-to-manufacturer prescription programs to explore broader pharmacy benefit models.

Geographic activity centers on Texas and Florida, with multistate cooperative purchasing extending into the Upper Midwest and Pacific Northwest. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued a major RFP in January 2026 for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities including Oregon, with a response deadline of March 26, 2026. Seminole County's IFB (Solicitation IFB60459723LAS) for naloxone procurement closed July 26, 2023, and the Texas HHS RFI (HHS0017013) on direct-to-manufacturer prescriptions closed April 3, 2026. None of these solicitations explicitly names ropinirole, suggesting the code may be overly broad or mismatched to actual recent procurement activity under this commodity designation.